李兆雷

    【摘要】 目的：分析老年慢性心力衰竭(CHF)治療中美托洛尔联合阿托伐他汀的临床疗效及对血清NT-proBNP、Cys C的影响。方法：选择本院2018年5月-2019年5月收治的78例老年CHF患者为研究对象。将其随机分为试验组和参照组，每组39例。参照组采用临床常规治疗，试验组在参照组基础上采用美托洛尔联合阿托伐他汀治疗。比较两组临床疗效、心功能指标、血清NT-proBNP、Cys C含量、不良反应发生情况。结果：试验组临床总有效率为94.87%，显著高于参照组的69.23%(P0.05)。结论：美托洛尔与阿托伐他汀联合可有效降低老年CHF患者机体血清

    NT-proBNP、Cys C含量，改善心功能，防止疾病加重、进展，且安全性高。

    【关键词】 美托洛尔 阿托伐他汀 慢性心力衰竭 血浆氨基末端脑钠肽前体 胱抑素C

    Metoprolol Combined with Atorvastatin for Elderly Efficacy of Chronic Heart Failure Patients and Its Effect on Serum NT-proBNP and Cys C/LI Zhaolei. //Medical Innovation of China， 2021， 18(07)： 0-055

    [Abstract] Objective： To analyze the clinical efficacy of Metoprolol combined with Atorvastatin in the treatment of elderly chronic heart failure (CHF) and its effect on serum NT-proBNP and Cys C. Method： A total of 78 elderly patients with CHF admitted to our hospital from May 2018 to May 2019 were selected as the research objects. They were randomly divided into experimental group and reference group ......